NEW YORK, April 4 – Sequenom said Wednesday it has sold three MassArray Systems, bringing the company’s installed base to 29 sites worldwide.
Sequenom of San Diego said the announcement includes the sale of a second system to the Whitehead Institute’s Center for Genome Research and initial sales to Galileo Genomics, a population genetics company based in Montreal, and to an undisclosed customer.
Sequenom did not say how much the systems sold for, but in the past the company has said that the price of the MassArray is between $400,000 and $1.1 million depending on consumables.
The news follows on the heals of an announcement last week in which Sequenom of San Diego said it completed the sale of four systems, including sales to customers in Europe and Korea.
The MassArray system, first commercialized in early 2000, provides a platform for genotyping experiments without the use of fluorescence or other tagging techniques. Instead, the company's technology applies MALDI-TOF mass spectrometry directly to fragments of DNA to detect SNPs.